Related Experiment Video
Updated: Apr 7, 2026
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility
Edward H Oldfield1, Mary Lee Vance1, Robert G Louis1
1Department of Neurological Surgery (E.H.O., R.G.L., C.L.P., J.A.J), Department of Medicine (M.L.V.), and Department of Pathology (M.-B.S.L.), University of Virginia Health System, Charlottesville, VA 22903.
Context:
Although Crooke's changes in the pituitary corticotrophs were initially described in 1935, the prevalence in which the changes occur in patients with Cushing's syndrome (CS) has not been established.
Objective:
This study aimed to determine the prevalence and assess clinical features associated with the presence or absence of Crooke's changes in a large set of patients with CS.
Design:
Information from a prospective computer database and retrospective chart review was analyzed.
Setting:
The setting was an academic medical center.
Patients:
Consecutive patients (N = 213) who received surgery with a preoperative diagnosis of Cushing's disease are included.
Intervention:
The patients received pituitary surgery and specimens obtained underwent pathological analysis.
Main Outcome Measure:
The presence or absence of Crooke's changes was determined by histopathological analysis of the normal pituitary tissue included with the specimen obtained at surgery. Cortisol production was measured by 24-hour urine cortisol production.
Results:
Crooke's changes occurred in 144 of 177 patients (81%) with a histologically demonstrated ACTH-staining tumor and in 74% of 213 patients diagnosed with CS who had pituitary surgery. The presence of Crooke's changes correlated with the finding of an ACTH-staining tumor removed at surgery and with the degree of hypercortisolism. Among patients with histologically established ACTH-staining tumors the prevalence of Crooke's changes was particularly high in patients with a 24-h urinary free cortisol (UFC) of at least 4-fold the upper limit of normal, in which 91% of patients had Crooke's changes, compared with 74% of patients whose maximum UFC was less than 4-fold the upper limit of normal (P = .008).
Conclusions:
Crooke's changes occur in 75-80% of patients with CS, and depend on the degree of hypercortisolism and individual variability. Almost all patients with UFC at least 4-fold the upper limit of normal have them, whereas with less severe hypercortisolism the expression of Crooke's changes varies from person to person.
Related Concept Videos
01:27Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:24Chronic Kidney Disease II: Clinical Manifestations
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
01:24Cystic Fibrosis: Management
Sinus disease and chronic...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:26COPD: Management Using Bronchodilators and Corticosteroids